Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Flamsa Reduced-Intensity Conditioning Regimen in AML Patients – Role of Re-Induction and Disease State Prior to Transplant

Udo Holtick, MDPhD, Alexander Shimabukuro-Vornhagen, MD, Geothy Chakupurakal, MBBS, MRCPath, PhD, Sebastian Theurich, MD, Silke Leitzke, Dominik Wolf, MD, Michael Hallek, MD, Michael S. von Bergwelt-Baildon, MD PhD, Christof Scheid, MDPhD, Jens Chemnitz, MD

Blood (2014) 124 (21): 3904.

https://doi.org/10.1182/blood.V124.21.3904.3904

Published: 2014

Journal Articles

p38 MAPK Controls Sensitivity Towards BH3 Mimetics By Regulating Mcl-1 Expression of Chronic Lymphocytic Leukemia in Hypoxia and Acquired Resistance

Malte F Huelsemann, Michaela Patz, PhD, Laura Beckmann, Kerstin Brinkmann, Teresa Otto, Joachim Fandrey, MD, Hans Jiro Becker, Sebastian Theurich, MD, Michael S. von Bergwelt-Baildon, MD PhD, Christian P. Pallasch, MD, Réne P. Zahedi, Hamid Kashkar, PhD, Christian Reinhardt, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD, Lukas P. Frenzel, MD

Blood (2014) 124 (21): 1947.

https://doi.org/10.1182/blood.V124.21.1947.1947

Published: 2014

Journal Articles

The CD21 low B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset

Alexander Shimabukuro-Vornhagen, MD, María García Márquez, Rieke Fischer, MD, Kerstin Wennhold, Juliane Iltgen, Sebastian Theurich, MD, Michael S. von Bergwelt-Baildon, MD PhD

Blood (2014) 124 (21): 1425.

https://doi.org/10.1182/blood.V124.21.1425.1425

Published: 2014

Journal Articles

Impact of Hypoxia As Novel Microenvironmental Factor On Drug Susceptibility of Primary CLL Cells

Malte Huelsemann, Lukas P. Frenzel, MD, Dunja Baatout, M.Sc., Julia Claasen, Sebastian Theurich, MD, Laurent Kintzelé, Hans Jiro Becker, Michaela Patz, PhD, Christian P. Pallasch, MD, Michael S. von Bergwelt-Baildon, MD, PhD, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2012) 120 (21): 3918.

https://doi.org/10.1182/blood.V120.21.3918.3918

Published: 2012

Journal Articles

Primed for Death: Hypoxia Sensitizes Primary CLL Cells towards Compounds Targeting Mitochondrial Integrity

Lukas P. Frenzel, MD, Malte Huelsemann, Julia Claasen, Reinhild Brinker, Sebastian Theurich, MD, Hans Jiro Becker, Michael S. von Bergwelt-Baildon, MD, PhD, Christian P. Pallasch, MD, Michael Hallek, MD, Clemens Wendtner, MD

Blood (2011) 118 (21): 1767.

https://doi.org/10.1182/blood.V118.21.1767.1767

Published: 2011

Journal Articles

Response: Friend or foe in GVHD: a matter of targeting the right B-cell subset

Alexander Shimabukuro-Vornhagen, Michael S. von Bergwelt-Baildon

Blood (2010) 115 (12): 2559–2560.

https://doi.org/10.1182/blood-2009-12-254821

Published: 2010

Journal Articles

The role of B cells in the pathogenesis of graft-versus-host disease

Alexander Shimabukuro-Vornhagen, Michael J. Hallek, Rainer F. Storb, Michael S. von Bergwelt-Baildon

Blood (2009) 114 (24): 4919–4927.

https://doi.org/10.1182/blood-2008-10-161638

Published: 2009

Journal Articles

MGN1703, a Novel TLR9-Agonist - Results of a Phase 1 Clinical Trial in Patients with Metastatic Malignancies.

Martin R Weihrauch, Manuel Schmidt, Marina Tschaika, Heike Richly, Michael S von Bergwelt-Baildon, Ulrich Hacker, Alexander Shimabokuro-Vornhagen, Burghardt Wittig, Max E Scheulen

Blood (2009) 114 (22): 4730.

https://doi.org/10.1182/blood.V114.22.4730.4730

Published: 2009

Journal Articles

Statins Inhibit the Function of Human Antigen-Presenting Cells

Alexander Shimabukuro-Vornhagen, MD, Tanja Liebig, Shahram Zoghi, Clemens M Wendtner, MD, Michael S von Bergwelt-Baildon, MD

Blood (2008) 112 (11): 2560.

https://doi.org/10.1182/blood.V112.11.2560.2560

Published: 2008

Journal Articles

Physical Exercise Is Possible in Patients with Critical Cytopenia Undergoing High- Dose Chemotherapy for Acute Leukaemia or Aggressive Lymphoma

Thomas Elter, MD, Freerk Baumann, Martina Stipanov, Eva Heuser, Michael S von Bergwelt-Baildon, Wilhelm Bloch, MD, Michael Hallek

Blood (2008) 112 (11): 4719.

https://doi.org/10.1182/blood.V112.11.4719.4719

Published: 2008

Journal Articles

CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition

Michael S. von Bergwelt-Baildon, Alexey Popov, Tomo Saric, Jens Chemnitz, Sabine Classen, Marc S. Stoffel, Francesca Fiore, Udo Roth, Marc Beyer, Svenja Debey, Claudia Wickenhauser, Franz-Georg Hanisch, Joachim L. Schultze

Blood (2006) 108 (1): 228–237.

https://doi.org/10.1182/blood-2005-08-3507

Published: 2006

Includes: Supplemental data

Journal Articles

Engagement of CD83 ligand induces prolonged expansion of CD8 + T cells and preferential enrichment for antigen specificity

Naoto Hirano, Marcus O. Butler, Zhinan Xia, Sascha Ansén, Michael S. von Bergwelt-Baildon, Donna Neuberg, Gordon J. Freeman, Lee M. Nadler

Blood (2006) 107 (4): 1528–1536.

https://doi.org/10.1182/blood-2005-05-2073

Published: 2006

Journal Articles

Autoantibodies frequently detected in patients with aplastic anemia

Naoto Hirano, Marcus O. Butler, Michael S. von Bergwelt-Baildon, Britta Maecker, Joachim L. Schultze, Kevin C. O'Connor, Peter H. Schur, Seiji Kojima, Eva C. Guinan, Lee M. Nadler

Blood (2003) 102 (13): 4567–4575.

https://doi.org/10.1182/blood-2002-11-3409

Published: 2003

Journal Articles

The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells

Britta Maecker, David H. Sherr, Robert H. Vonderheide, Michael S. von Bergwelt-Baildon, Naoto Hirano, Karen S. Anderson, Zhinan Xia, Marcus O. Butler, Kai W. Wucherpfennig, Carl O'Hara, Geoffrey Cole, Silvia S. Kwak, Urban Ramstedt, Andy J. Tomlinson, Roman M. Chicz, Lee M. Nadler, Joachim L. Schultze

Blood (2003) 102 (9): 3287–3294.

https://doi.org/10.1182/blood-2003-05-1374

Published: 2003

Journal Articles

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

Michael S. von Bergwelt-Baildon, Robert H. Vonderheide, Britta Maecker, Naoto Hirano, Karen S. Anderson, Marcus O. Butler, Zhinan Xia, Wan Y. Zeng, Kai W. Wucherpfennig, Lee M. Nadler, Joachim L. Schultze

Blood (2002) 99 (9): 3319–3325.

https://doi.org/10.1182/blood.V99.9.3319

Published: 2002

NARROW

Flamsa Reduced-Intensity Conditioning Regimen in AML Patients – Role of Re-Induction and Disease State Prior to Transplant

p38 MAPK Controls Sensitivity Towards BH3 Mimetics By Regulating Mcl-1 Expression of Chronic Lymphocytic Leukemia in Hypoxia and Acquired Resistance

The CD21 low B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset

Impact of Hypoxia As Novel Microenvironmental Factor On Drug Susceptibility of Primary CLL Cells

Primed for Death: Hypoxia Sensitizes Primary CLL Cells towards Compounds Targeting Mitochondrial Integrity

Response: Friend or foe in GVHD: a matter of targeting the right B-cell subset

The role of B cells in the pathogenesis of graft-versus-host disease

MGN1703, a Novel TLR9-Agonist - Results of a Phase 1 Clinical Trial in Patients with Metastatic Malignancies.

Statins Inhibit the Function of Human Antigen-Presenting Cells

Physical Exercise Is Possible in Patients with Critical Cytopenia Undergoing High- Dose Chemotherapy for Acute Leukaemia or Aggressive Lymphoma

CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition

Engagement of CD83 ligand induces prolonged expansion of CD8 + T cells and preferential enrichment for antigen specificity

Autoantibodies frequently detected in patients with aplastic anemia

The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only